These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32189325)

  • 41. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The size of the treatment effect: do patients and proxies agree?
    van der Linden FA; Kragt JJ; Hobart JC; Klein M; Thompson AJ; van der Ploeg HM; Polman CH; Uitdehaag BM
    BMC Neurol; 2009 Mar; 9():12. PubMed ID: 19317921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.
    Goodwin E; Green C
    Value Health; 2015 Dec; 18(8):1016-24. PubMed ID: 26686786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
    Wolkorte R; Heersema DJ; Zijdewind I
    Neurorehabil Neural Repair; 2015 Sep; 29(8):796-802. PubMed ID: 25605633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis.
    Sonder JM; Holman R; Knol DL; Bosma LV; Polman CH; Uitdehaag BM
    J Neurol Sci; 2013 Nov; 334(1-2):143-7. PubMed ID: 24018128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Personal Resources in Patients Who Differently Estimate the Impact of Multiple Sclerosis.
    Wilski M; Tomczak M
    Ann Behav Med; 2017 Apr; 51(2):179-188. PubMed ID: 27679463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do patient and proxy agree? Long-term changes in multiple sclerosis physical impact and walking ability on patient-reported outcome scales.
    Sonder JM; Balk LJ; Bosma LV; Polman CH; Uitdehaag BM
    Mult Scler; 2014 Oct; 20(12):1616-23. PubMed ID: 24710798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fear of falling, not falls, impacts leisure-time physical activity in people with multiple sclerosis.
    Kalron A; Aloni R; Givon U; Menascu S
    Gait Posture; 2018 Sep; 65():33-38. PubMed ID: 30558943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use.
    van der Linden FA; Kragt JJ; Klein M; van der Ploeg HM; Polman CH; Uitdehaag BM
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1677-81. PubMed ID: 16291893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study.
    Cambil-Martín J; Galiano-Castillo N; Muñoz-Hellín E; Díaz-Rodríguez L; Laguarta-Val S; Fernández-de-Las-Peñas C; Arroyo-Morales M
    Nutr Neurosci; 2016; 19(2):79-85. PubMed ID: 25225836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of an 1-day education program on physical functioning, activity and quality of life in community living persons with multiple sclerosis.
    Feys P; Tytgat K; Gijbels D; De Groote L; Baert I; Van Asch P
    NeuroRehabilitation; 2013; 33(3):439-48. PubMed ID: 23949075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between depression, anxiety and cognition and its paradoxical impact on falls in multiple sclerosis patients.
    Kalron A; Aloni R; Allali G
    Mult Scler Relat Disord; 2018 Oct; 25():167-172. PubMed ID: 30086536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coping strategies and quality of life in Mexican multiple sclerosis patients: Physical, psychological and social factors relationship.
    Hernández-Ledesma AL; Rodríguez-Méndez AJ; Gallardo-Vidal LS; Trejo-Cruz G; García-Solís P; Dávila-Esquivel FJ
    Mult Scler Relat Disord; 2018 Oct; 25():122-127. PubMed ID: 30071505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients.
    Adamczyk-Sowa M; Pierzchala K; Sowa P; Polaniak R; Kukla M; Hartel M
    J Physiol Pharmacol; 2014 Aug; 65(4):543-50. PubMed ID: 25179086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal proxy measurements in multiple sclerosis: patient-proxy agreement on the impact of MS on daily life over a period of two years.
    van der Linden FA; Kragt JJ; van Bon M; Klein M; Thompson AJ; van der Ploeg HM; Polman CH; Uitdehaag BM
    BMC Neurol; 2008 Feb; 8():2. PubMed ID: 18307788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of relationship between social capital and quality of life in multiple sclerosis patients.
    Rimaz S; Mohammad K; Dastoorpoor M; Jamshidi E; Majdzadeh R
    Glob J Health Sci; 2014 Aug; 6(6):261-72. PubMed ID: 25363095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial.
    Kehoe M; Saunders J; Jakeman P; Coote S
    Mult Scler; 2015 Apr; 21(5):590-8. PubMed ID: 25209170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.
    Riazi A; Hobart JC; Lamping DL; Fitzpatrick R; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):701-4. PubMed ID: 12438473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.